We have specialists catering to every aspect of our life except the poison that we pump into our body as drugs; all specialists are in control of their destiny except pharmacists that are treated like children in their supposed area of jurisdiction; pharmacists are overeducated, underutilized and marginalized medical practitioners; drugs are chemicals and chemicals are poisons. The drugs we pump into our body at dawn can send us to our grave at dusk instead of ameliorating our condition. It is in light of these facts that this book was written to buttress the plight of pharmacists, pharmacy profession and the need to liberate the profession from slavery for the benefit of mankind. The book debits an accurate historical account of pharmacy, its slavery status, subservience, topsy-turvy fame, service to humanity and awesome contribution to the healthcare system of US/World. It also elaborates the history and shortcomings of other branches of medicine. Dean Grossman of LIU School of Pharmacy, Drug Topics survey of drug manufacturing company executives, research studies in the book, study upon study, and others vindicate clinical pharmacists as the most knowledgeable medical practitioners about drugs/medications in the medical field yet they have to obtain permission for drug usage from other branches of medicine that do not know as much about the profession as the practitioners. Something must be inherently wrong in a system that relegates or subjugates the best at the altar of tradition and societal indoctrination. These issues contained in the book were evident everywhere during my tour of the sic habitable continents of the world (China and India in Asia, Nigeria in Africa, Australia, UK and France in Europe, Brazil in South America and US in North America). Pharmacy/pharmacist is a branch of medicine and not an errand boy of medicine.

A single trial is complex, with numerous regulations, administrative processes, medical procedures, deadlines and specific protocol instructions to follow. And yet, there has existed no single-volume, comprehensive clinical research reference manual for investigators, medical institutions, and national and international research personnel to keep on the shelf as a ready reference to navigate through trial complexities and ensure compliance with U.S. Federal Regulations and ICH GCP until The Sourcebook for Clinical Research. An actionable, step-by-step guide through beginning to advanced topics in clinical research with forms, templates and checklists to download from a companion website, so that study teams will be compliant and will find all the necessary tools within this book. Additionally, the authors developed Display Posters for Adverse Events Plus Reporting and Medicare Coverage Analysis that can be purchased separately here: https://www.elsevier.com/books-and-journals/book-companion/9780128162422/order-display-posters. Moreover, The Sourcebook for Clinical Research contains clear information and guidance on the newest changes in the industry to keep seasoned investigators and staff current and compliant, in addition to providing detailed information regarding the most complex topics. This book serves as a quick, actionable, off-the-shelf resource to keep by your side at the medical clinic.

In the early twentieth century lead had many domestic uses: in solder for cans, as a gasoline additive to prevent ""knocking"" in engines, in water pipes, and, most prominently, in interior paint prized for its durability and ability to hold color. Far from being the toxic hazard we recognize today, lead was a valuable commodity. However, by the end of the century, lead had largely disappeared from our environment as physicians discovered the threat it posed to children's health and mental development. Old Paint documents the history of lead-paint poisoning in the United States and the evolving responses of public health officials and the lead-paint industry to this hazard up to 1980, by which time lead had been banned from gasoline and paint. Peter C. English traces lead poisoning from a rare, but acute problem confined to a small group of children to the discovery by the end of the 1940s of the dangers of the crumbling lead-painted interiors of inner-city dwellings. He draws on a wide range of primary materials not only to illuminate our understanding of how this health hazard changed over time, but also to explore how diseases are constructed and evolve.

Peptidomics of Cancer-Derived Enzyme Products, Volume 42, the latest in The Enzymes series, is ideal for researchers in biochemistry, molecular and cell biology, pharmacology, and cancer, with this volume featuring high-caliber, thematic articles on the topic of peptidomics of cancer-derived enzyme products. Specific chapters cover Circulating peptidome and tumor-resident proteolysis, Colon tumor secretopeptidome, Chemoenzymatic method for glycomics, Human plasma peptidome for pancreatic cancer, Lipoproteomics and quantitative proteomics, Salivaomics: Protein markers/extracellular RNA/DNA in saliva, and Enzyme-responsive vectors for cancer therapy.

Coumarins are a group of compounds that have important roles as food constituents; as anti-oxidants, stabilisers, and immunomodulatory substances; as fluorescent markers for use in analysis, in lasers and in clinical use. Coumarins: Biology, Applications and Mode of Action predominantly focuses on the parent compound, coumarin, and its main metabolite in humans, 7-hydroxycoumarin. It describes in detail every facet of these compounds including history, toxicology, chemistry, metabolism, analysis, clinical, veterinary and other applications, their roles as immunomodulatory agents and speculates on their mode of action. Features include:
* New insights into mode of action of coumarins
* Comprehensive summary of new coumarin compounds
* Detailed accounts of methods used for analysis
* Applications of coumarins for diverse methods of analysis
This volume will be of interest to those working in biochemistry, chemistry, pharmacology, clinical sciences and toxicology.

Vascular Pharmacology: Cytoskeleton and Extracellular Matrix, Volume 81, contains the latest information on the vascular cytoskeleton and extracellular matrix that is presented with helpful illustrations and supporting references by prominent scientists and highly-recognized experts in the vascular field. Topics of interest in this new release include Pharmacology of the Vascular Cytoskeleton and Extracellular Matrix, The Dynamic Actin Cytoskeleton in Smooth Muscle, The Role of the Actin Cytoskeleton in the Regulation of Vascular Inflammation, The Smoothelin Family of Proteins and the Smooth Muscle Cell Contractile Apparatus, Smooth Muscle Cytoskeletal Network Regulates Expression of the Profibrotic Genes PAI-1 and CTGF, and more.

History of Risk Assessment in Toxicology guides the reader through the historical narrative of the evolution of risk assessment thinking in human and environmental practices. Risk assessment concepts are used in many different professional practice areas. In the health and environmental practices of risk assessment, the critical issue is often what chemical concentration in air, water, food, or a solid substance is acceptable, or considered not to result in any adverse effect. The book reviews examples from early scientific and health studies to showcase the foundations of risk assessment. The book also explores the development of risk assessment as practiced by major regulatory bodies such as the US Food and Drug Administration (FDA), the Occupational Safety & Health Administration (OSHA), and the US Environmental Protection Agency (EPA) to reveal how risk assessment has evolved in the 20th and 21st centuries. Modern technology has created opportunities in silicon in vitro, computational modeling, omics, and big data techniques to assess the toxicity of chemicals, while traditional approaches to risk assessment are being challenged with new and innovative approaches. Finally, current issues being debated and tested in risk assessment are outlined with possible future avenues suggested.

There has been a growing concern for the improvement of pharmaceutical services provided by healthcare institutions. This concern is also shared by other stakeholders including patients, regulatory organizations, pharmaceutical companies, insurance companies, and research institutions.Advancing Pharmaceutical Processes and Tools for Improved Health Outcomes presents research-based perspectives on the pharmaceutical industry in today's digitally-fueled world. Focusing on technological innovations for pharmaceutical applications as well as current trends in the industry, this publication is ideally designed for use by pharmacists, medical professionals, administrators in the medical field, health insurance professionals, researchers, and graduate-level students.

This book provides a timely state-of-the-art overview of voltage-gated sodium channels, their structure-function, their pharmacology and related diseases. Among the topics discussed are the structural basis of Na+ channel function, methodological advances in the study of Na+ channels, their pathophysiology and drugs and toxins interactions with these channels and their associated channelopathies.

Platform Technologies in Drug Discovery and Validation, Volume 50, the latest release in the Annual Reports in Medicinal Chemistry series, provides timely and critical reviews of important topics in medicinal chemistry, with an emphasis on emerging topics in the biological sciences. Topics covered in this new volume include DELT, Oligos: ASO, siRNA, CRISPR, Micro-fluidic chemistry, High throughput screening, Kinase-centric computational drug development, Virtual Screening, Phenotypic screening, PROTACS, Chemical Biology, Fragment-based lead generation, Antibody-Drug Conjugates, Antibody-recruiting small molecules, Deuteration, and Peptides.

At a time when genetics and informatics are seen to transform therapeutic thinking once again, it is pertinent to look back to earlier therapeutic regimes. The long twentieth century has witnessed a tremendous upsurge in new drugs, remedies and therapeutic strategies. The cultural environments in which they emerged, the social circumstances from which they sprang, and the social effects that remedies engendered are treated in depth in this collection of essays. They address the historical variety of remedies as economic, social, and cultural objects and discuss their particular forms of production and distribution. Drawing predominantly on British and Dutch cases, the curious 'biographies' of modern drugs like streptomycin, taxol and interferon are reviewed, the shifting boundaries between medicines and toxic substances are explored, and remedial strategies such as contraceptives are scrutinised. This book, which emerged out of an Anglo-Dutch conference held in 1998, explores cultures of remedies from a comparative perspective.

This book addresses various clinical and sub clinical applications of antioxidant nutraceuticals, with a primary focus on preventive use for general wellness, common ailments, and such chronic illnesses as cancer and neurological applications. This unique book captures the applications of natural antioxidants, which have been used for thousands of years in Traditional Chinese Medicine and Ayurvedic Medicine as well as modern nutraceuticals formulations. It covers antioxidant applications in clinical scenarios including the historical perspective, basic antioxidant properties and applications, anti-inflammatory properties, and antioxidant applications in a variety of clinical conditions.

Anthrax is only one of many biological threats. We read and hear about the others in the news: mad cow disease, shark attacks, killer bees, the West Nile virus, polluted wells-countless stories of biological hazards in the U.S. and around the world. This compact reference handbook covers everything from disease-causing viruses and bacteria, to harmful insects, poisonous plants, dangerous animals, and other types of living threats to human life. Readers will learn the nature of these hazards, the associated risks, and where to find information for further study and research. Topics include: Human Pathogens in Water Human Pathogens in Food Human Pathogens in Air Human Pathogens Transmitted by Contact Crop and Livestock Pathogens and Pests Toxins and Allergens Predators and Other Biological Hazards Hazard and Controversy. In each category, the author presents the current scientific knowledge on causes, preventive measures, costs, outlook, and other topics of interest. Historical contexts are also provided. Every chapter ends with an anecdote illustrating its major themes. Primary source documents, statistical information, and a glossary are added features that make this resource the ideal starting point for anyone interested in biological hazards.

Ranunculales Medicinal Plants: Biodiversity, Chemodiversity and Pharmacotherapy comprehensively covers this order of flowering plants, detailing the phytochemistry, chemotaxonomy, molecular biology, and phylogeny of selected medicinal plants families and genera and their relevance to drug efficacy. The book carries out an exhaustive survey of the literature in order to characterize global trends in the application of flexible technologies. The interrelationship between Chinese species, and between Chinese and non-Chinese species, is inferred through molecular phylogeny and based on nuclear and chloroplast DNA sequencing. The book discusses the conflict between chemotaxonomy and molecular phylogeny in the context of drug discovery and development. Users will find invaluable and holistic coverage on the study of Ranunculales that will make this the go-to pharmaceutical resource.

This dictionary spans the practice of pharmacology, and of allied sciences insofar as they are related to it, with particular emphasis on the development, regulation and use of human medicine. It is offered to students as well as to professionals in pharmacology and allied sciences for "reference" and for "browsing," and as a bedside book and travelling companion. Its size (approximately 2000 entries) is appropriate for these uses.

Features of this dictionary:

- Provides definitions of terms in pharmacology, both basic and clinical

- Gives information on new medicine development and official regulations

- Covers allied topics, including statistics, ethics, scientific miscounduct, authorship, publication and law.